SCHEMBL4279013

SCHEMBL4279013

COC(=O)c1ccc(S(C)(=O)=O)c(C(=O)Cl)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.40
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
CA9 Q16790 2/20 0.40
CA5A P35218 1/20 0.40
ABL1 P00519 1/20 0.40
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CDK1 P06493 1/20 0.38
KMT2A Q03164 1/20 0.37
PDK2 Q15119 2/20 0.36
PDK4 Q16654 2/20 0.36
PDK1 Q15118 1/20 0.36
PDK3 Q15120 1/20 0.36
CA12 O43570 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4278676 0.88 VCAM1 (0.40) VCAM1CA2CA1CA9CA5A
SCHEMBL4267413 0.87 CA2 (0.42) VCAM1CA2CA1CA9CA5A
SCHEMBL8132556 0.84 MAPT (0.41) VCAM1CA2CA1CA9CA5A
SCHEMBL8132228 0.83 LMNA (0.42) CA2CA1CA9CA5ASMN1; SMN2
SCHEMBL17859583 0.82 VCAM1 (0.40) VCAM1CA2CA1CA9CA5A
SCHEMBL9079062 0.82 VCAM1 (0.40) VCAM1CA2CA1CA9CA5A
SCHEMBL4268094 0.81 KDM4E (0.44) VCAM1CA2CA1CA9CA5A
SCHEMBL7627991 0.81 MITF (0.43) VCAM1CA2CA1CA9CA5A
SCHEMBL30230387 0.80 CA1 (0.41) VCAM1CA2CA1CA9CA5A
SCHEMBL29182498 0.80 CA2 (0.41) VCAM1CA2CA1CA9CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045465-B1 3-heterocyclyl-substituted benzoyl derivatives BASF SE (DE) 2015-06-02 US disclosed
US-7608564-B2 3-heterocyclyl-substituted benzoyl derivatives BASF AKTIENGESELLSCHAFT (DE) 2009-10-27 US disclosed
US-20080039327-A1 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof DEYN WOLFGANG V 2008-02-14 US disclosed
US-7232792-B2 3-heterocyclyl-substituted benzoyl derivatives BASF AKTIENGESELLSCHAFT (DE) 2007-06-19 US disclosed
US-6576596-B1 Compatible with crop plants BASF AKTIENGESELLSCHAFT (DE) 2003-06-10 US disclosed
US-20020025910-A1 3-heterocycly1 - substituted benzoyl derivatives DEYN WOLFGANG VON (DE) 2002-02-28 US disclosed
US-6310245-B1 FOR CONTROLLING UNDESIRABLE VEGETATION; CROP PROTECTION BASF AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed
US-6165944-A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed
US-6028035-A HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020025910-A1 3-heterocycly1 - substituted benzoyl derivatives CBR3, CBR1, RRS1 VCAM1 4330/4885CA2 1632/4885CA1 2703/4885
US-20080039327-A1 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof CBR3, CBR1, GLRX3 VCAM1 4865/4885CA2 1348/4885CA1 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.